2016
DOI: 10.1016/j.ejmp.2016.08.014
|View full text |Cite
|
Sign up to set email alerts
|

In silico comparison of photons versus carbon ions in single fraction therapy of lung cancer

Abstract: Stereotactic body image guided radiation therapy (SBRT) shows excellent results for the local control of early stage lung cancer. However, not all patients are eligible for SBRT, and advanced stage treatment is less successful and often associated with severe side effects. Scanned carbon ion therapy (PT) can deliver more conformal dose likely benefiting these patient groups.Therefore an in silico trial was conducted on early and advanced stage patients to identify potential advantages of PT. The patients were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 173 publications
(246 reference statements)
1
14
0
Order By: Relevance
“…Given the location of the target in the heart, cardiac exposure will by necessity be high. Particle therapy according to planning studies can reduce cardiac doses drastically in comparison to photons in lung cancer patients, which also appears to be true for arrhythmia ablation . If the additional challenges of particles for moving targets can be overcome to assure safe dose coverage, these dosimetric advantages will be a strong factor in patient selection and risk‐benefit analysis.…”
Section: Discussionmentioning
confidence: 99%
“…Given the location of the target in the heart, cardiac exposure will by necessity be high. Particle therapy according to planning studies can reduce cardiac doses drastically in comparison to photons in lung cancer patients, which also appears to be true for arrhythmia ablation . If the additional challenges of particles for moving targets can be overcome to assure safe dose coverage, these dosimetric advantages will be a strong factor in patient selection and risk‐benefit analysis.…”
Section: Discussionmentioning
confidence: 99%
“…Target and OAR contours, which were delineated in the end‐inhale reference phase, were propagated to other motion phases through deformable image registration (DIR). The clinical target volume (CTV) was 1.6 cm3 in size and was situated in the left superior lung 21 …”
Section: Methodsmentioning
confidence: 99%
“…The clinical target volume (CTV) was 1.6 cm 3 in size and was situated in the left superior lung. 21 The plan was recalculated for a carbon ion therapy treatment using a fraction dose of 3.5 GyE in accordance with a regimen of 70 GyE in 20 fractions prescribed for centrally located disease at Shanghai Proton and Heavy Ion Center (SPHIC). 22 The biologically effective doses were computed using LEM IV assuming an 𝛼∕𝛽 of 6 and 2 for the target and for OARs, respectively.…”
Section: Patient Data and Treatment Planningmentioning
confidence: 99%
“…The DIR was performed with Plastimatch, using two successive registrations with a B-Spline algorithm [ 11 ]. The quality of the 4DCT DIR was assessed using the platform 3D Slicer [ 12 ], in particular using the Registration Quality Module [ 13 ], which was developed by external contributors as a set of tools that can be incorporated into 3D Slicer. The evaluation was performed through visual inspection and numerical quantification, such as the determinant of the Jacobian matrix (JD) of the vector field, inverse consistency error (ICE) and mean absolute difference.…”
Section: Methodsmentioning
confidence: 99%